Gene · 54583
Papers3,727
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,727
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Emerging roles of extracellular vesicle-associated non-coding RNAs in hypoxia: Insights from cancer, myocardial infarction and ischemic stroke. | Theranostics | 2022 | 35966580 | PubTator, text mining | PubMed |
| Chronic constant light exposure aggravates high fat diet-induced renal injury in rats. | Front Endocrinol (Lausanne) | 2022 | 35966094 | PubTator, text mining | PubMed |
| Mutational Profile and Potential Molecular Therapeutic Targets of Pheochromocytoma. | Front Endocrinol (Lausanne) | 2022 | 35966080 | PubTator, text mining | PubMed |
| Identifying α-KG-dependent prognostic signature for lower-grade glioma based on transcriptome profiles. | Front Oncol | 2022 | 35965532 | PubTator, text mining | PubMed |
| Effects of idiopathic erythrocytosis on the left ventricular diastolic functions and the spectrum of genetic mutations: A case control study. | Medicine (Baltimore) | 2022 | 35960118 | PubTator, text mining | PubMed |
| Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer. | J Exp Clin Cancer Res | 2022 | 35953814 | PubTator, text mining | PubMed |
| Nine quick tips for pathway enrichment analysis. | PLoS Comput Biol | 2022 | 35951505 | PubTator, text mining | PubMed |
| Concordance between Ki-67 index in invasive breast cancer and molecular signatures: EndoPredict and MammaPrint. | Mol Clin Oncol | 2022 | 35949891 | PubTator, text mining | PubMed |
| HIF1, HSF1, and NRF2: Oxidant-Responsive Trio Raising Cellular Defenses and Engaging Immune System. | Chem Res Toxicol | 2022 | 35948068 | PubTator, text mining | PubMed |
| TRABID targets DDB2 for deubiquitination to promote proliferation of hepatocellular carcinoma cells. | Biochem Biophys Res Commun | 2022 | 35944360 | PubTator, text mining | PubMed |
| The Plasmodium falciparum Nuclear Protein Phosphatase NIF4 Is Required for Efficient Merozoite Invasion and Regulates Artemisinin Sensitivity. | mBio | 2022 | 35938722 | PubTator, text mining | PubMed |
| A Novel PHD2/VHL-mediated Regulation of YAP1 Contributes to VEGF Expression and Angiogenesis. | Cancer Res Commun | 2022 | 35937460 | PubTator, text mining | PubMed |
| Widespread hydroxylation of unstructured lysine-rich protein domains by JMJD6. | Proc Natl Acad Sci U S A | 2022 | 35930668 | PubTator, text mining | PubMed |
| Crosstalk between the CBM complex/NF-κB and MAPK/P27 signaling pathways of regulatory T cells contributes to the tumor microenvironment. | Front Cell Dev Biol | 2022 | 35927985 | PubTator, text mining | PubMed |
| Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia-Inducible Factor Prolyl-4-Hydroxylase Inhibitor, for the Potential Treatment of Renal Anemia. | J Pharmacol Exp Ther | 2022 | 35926869 | PubTator, text mining | PubMed |
| The Functional Mechanism of MicroRNA in Oral Lichen Planus. | J Inflamm Res | 2022 | 35923905 | PubTator, text mining | PubMed |
| Non-coding RNAs in lung cancer: emerging regulators of angiogenesis. | J Transl Med | 2022 | 35918758 | PubTator, text mining | PubMed |
| von Willebrand Factor Is Produced Exclusively by Endothelium, Not Neointima, in Occlusive Vascular Lesions in Both Pulmonary Hypertension and Atherosclerosis. | Circulation | 2022 | 35914017 | PubTator, text mining | PubMed |
| Hypoxia aggravates ferroptosis in RPE cells by promoting the Fenton reaction. | Cell Death Dis | 2022 | 35906211 | PubTator, text mining | PubMed |
| CNN1 Represses Bladder Cancer Progression and Metabolic Reprogramming by Modulating HIF-1α Signaling Pathway. | Front Oncol | 2022 | 35903683 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54583/papers?page=39